Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Similar Journals
Journal Cover
JAMA The Journal of the American Medical Association
Journal Prestige (SJR): 8.876
Citation Impact (citeScore): 7
Number of Followers: 2390  
 
  Full-text available via subscription Subscription journal
ISSN (Print) 0098-7484 - ISSN (Online) 1538-3598
Published by American Medical Association Homepage  [14 journals]
  • Audio Highlights

    • Free pre-print version: Loading...

      First page: e2318304
      Abstract: Listen to the JAMA Editor’s Audio Summary for an overview and discussion of the important articles appearing in this week’s issue of JAMA.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2023.18304
      Issue No: Vol. 331, No. 21 (2024)
       
  • JAMA

    • Free pre-print version: Loading...

      Pages: 1783 - 1784
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2023.18303
      Issue No: Vol. 331, No. 21 (2024)
       
  • Fritz Kahn and the Centenary of the Doctor of the Future

    • Free pre-print version: Loading...

      Pages: 1786 - 1788
      Abstract: This JAMA Arts and Medicine feature describes ways in which Fritz Kahn shared a prescient and nuanced vision of technology’s role in the patient-physician interaction, a topic of continued interest and relevance today, through his illustrations.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.6041
      Issue No: Vol. 331, No. 21 (2024)
       
  • Why the Bird Flu Outbreak in Dairy Cows Matters

    • Free pre-print version: Loading...

      Pages: 1789 - 1791
      Abstract: This Medical News article discusses the current H5N1 avian influenza outbreak in US dairy cattle and its implications for occupational and public health.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.8886
      Issue No: Vol. 331, No. 21 (2024)
       
  • College Athlete Deaths by Suicide Have Doubled

    • Free pre-print version: Loading...

      Pages: 1792 - 1794
      Abstract: This Medical News story discusses an analysis of deaths by suicide among NCAA athletes over the past 20 years.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7895
      Issue No: Vol. 331, No. 21 (2024)
       
  • National Academies Report: COVID-19 Vaccines Don’t Cause Many
           Potential Harms

    • Free pre-print version: Loading...

      Pages: 1795 - 1795
      Abstract: The COVID-19 vaccines made by Pfizer-BioNTech and Moderna do not cause such conditions as female infertility, myocardial infarction, Bell palsy, or Guillain-Barré syndrome in adults, according to a report by the National Academies of Sciences, Engineering, and Medicine that reviewed evidence for potential harms for 19 conditions associated with these vaccines. There was not enough evidence involving children to draw conclusions about possible harms.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7724
      Issue No: Vol. 331, No. 21 (2024)
       
  • Two-Thirds of Unhoused People Have Mental Health Disorders

    • Free pre-print version: Loading...

      Pages: 1795 - 1795
      Abstract: The majority of people who are currently unhoused—67%—have mental health disorders, according to a systematic review and meta-analysis of 85 studies mainly from Canada, Germany, and the US involving more than 48 400 participants. The lifetime prevalence of mental health disorders among people experiencing homelessness was 77%. The lifetime prevalence was higher among male than female individuals: 85% vs 69%, respectively.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7725
      Issue No: Vol. 331, No. 21 (2024)
       
  • Clinicians Underprescribe Newer Antibiotics for Drug-Resistant Disease

    • Free pre-print version: Loading...

      Pages: 1795 - 1795
      Abstract: About 42% of patients with infections caused by pathogens that were resistant to all first-line antibiotics received only older antibiotics rather than newer ones more recently approved by the US Food and Drug Administration, a new study found. The results were based on data from 619 US hospitals and more than 2600 infections caused by drug-resistant gram-negative pathogens.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7726
      Issue No: Vol. 331, No. 21 (2024)
       
  • Five-in-One Meningitis Vaccine Rolls Out

    • Free pre-print version: Loading...

      Pages: 1795 - 1795
      Abstract: Nigeria will be the first country in the world to vaccinate residents aged 1 through 29 years with Men5CV, a novel 1-dose vaccine that protects people from 5 major strains of the meningococcus bacteria (Neisseria meningitidis), the World Health Organization (WHO) announced. The news comes amid a 50% surge in meningitis cases in Africa last year, as well as an uptick in the disease worldwide, including in the US.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7727
      Issue No: Vol. 331, No. 21 (2024)
       
  • Permanent Procedures to Prevent Pregnancy in US Jumped After Dobbs

    • Free pre-print version: Loading...

      Pages: 1795 - 1796
      Abstract: The number of young people who sought permanent contraception—such as tubal ligations or vasectomies—rose immediately after the US Supreme Court’s decision in Dobbs v Jackson Women’s Health Organization, researchers reported in JAMA Health Forum. The data came from US patients aged 18 to 30 years.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7728
      Issue No: Vol. 331, No. 21 (2024)
       
  • Deprescribing Program Tied to Reductions in PPI Use in US

    • Free pre-print version: Loading...

      Pages: 1796 - 1796
      Abstract: Previous studies have suggested that many people who use proton pump inhibitors (PPIs) might not have a clinical indication for doing so, which is concerning because PPIs have been associated with chronic kidney disease and infection in some observational studies. Now, recent results published in The BMJ show that an intervention targeting overprescribing of PPIs might lead to quick, lasting reductions in their use.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7729
      Issue No: Vol. 331, No. 21 (2024)
       
  • Exercise Might Lower Heart Disease Risk in Part By Decreasing Stress in
           the Brain

    • Free pre-print version: Loading...

      Pages: 1796 - 1796
      Abstract: Physical activity might reduce the risk of cardiovascular disease partly by decreasing activity in parts of the brain related to stress, a study in the Journal of the American College of Cardiology suggests. Researchers looked at data from more than 50 300 adults in Massachusetts who completed an exercise survey and more than 700 who underwent brain imaging. People who exercised more tended to have fewer cardiovascular disease events and lower activity in stress-related brain regions, the researchers reported.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7730
      Issue No: Vol. 331, No. 21 (2024)
       
  • Study: Stigma in Medical Records Tied to Diagnostic Errors

    • Free pre-print version: Loading...

      Pages: 1796 - 1796
      Abstract: Patients who were affected by diagnostic errors were more likely to have stigmatizing language in their medical records, according to a new analysis in JAMA Internal Medicine. The cohort study involved more than 2300 hospital admissions during which patients died or were transferred to the intensive care unit. Stigmatizing language included phrases that questioned a patient’s credibility, stereotyped them by race or social class, or implied that the patient was “difficult.” It was more common among Black patients and those with housing instability.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7731
      Issue No: Vol. 331, No. 21 (2024)
       
  • Imaging Approach Tracked Subtle Changes Linked With Mild Brain Injury

    • Free pre-print version: Loading...

      Pages: 1796 - 1796
      Abstract: Currently, there are few reliable tools for diagnosing mild traumatic brain injuries or predicting their likely course, which can include poor neuropsychiatric outcomes. But results published in JAMA Network Open show that an advanced form of magnetic resonance imaging picked up changes in the brain’s white matter microstructure among military service members with mild traumatic brain injuries. The researchers examined 65 male participants who had experienced a head injury more than 2 years ago and 33 service members who hadn’t.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7732
      Issue No: Vol. 331, No. 21 (2024)
       
  • Assessing the Real-World Effectiveness of Immunizations for Respiratory
           Syncytial Virus

    • Free pre-print version: Loading...

      Pages: 1799 - 1800
      Abstract: This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.5859
      Issue No: Vol. 331, No. 21 (2024)
       
  • Safeguarding Research Using Federal Health Insurance Data

    • Free pre-print version: Loading...

      Pages: 1801 - 1802
      Abstract: This Viewpoint discusses the importance of researcher access to federal health care data following a CMS decision to limit the use of physical data and proposes solutions to maintain access and security.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.5943
      Issue No: Vol. 331, No. 21 (2024)
       
  • Best Versions of Ourselves

    • Free pre-print version: Loading...

      Pages: 1803 - 1804
      Abstract: In this narrative medicine essay, a lecturer in narrative medicine strives to accept her best self by surmounting the barriers of itchy skin and unsightly red patches caused by chronic atopic dermatitis.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.5616
      Issue No: Vol. 331, No. 21 (2024)
       
  • PhALLCON Soars to New Heights—Faster, Stronger, but Better'

    • Free pre-print version: Loading...

      Pages: 1805 - 1806
      Abstract: In this issue of JAMA, Jabbour and colleagues report results from the interim analysis of the PhALLCON randomized trial with ponatinib vs imatinib, combined with reduced-intensity chemotherapy. They found ponatinib to have superior efficacy and a comparable safety profile for frontline treatment of adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL). On the heels of these results, the US Food and Drug Administration granted ponatinib accelerated approval for this indication on March 19, 2024.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.5871
      Issue No: Vol. 331, No. 21 (2024)
       
  • Heart Failure in African American Individuals, Version 2.0

    • Free pre-print version: Loading...

      Pages: 1807 - 1808
      Abstract: An antecedent body of work established nearly 20 years ago benchmarked the nuanced distinctions of heart failure affecting African American people. Summative statements established a nearly 2-fold higher incidence, earlier onset, greater severity at the time of diagnosis, a more likely nonischemic etiology, a putative pathophysiology attributed to hypertensive heart disease, greater morbidity, and in younger ages (45-64 years) higher mortality. The coincident burden of adverse social determinants of health further delineates the disproportionate burden of heart failure in African American individuals. Given that race is a social construct, this peculiar predilection for a nonischemic heart failure phenotype requires further investigation.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.5217
      Issue No: Vol. 331, No. 21 (2024)
       
  • Addressing Health Disparities—The Case for Variant Transthyretin Cardiac
           Amyloidosis Grows Stronger

    • Free pre-print version: Loading...

      Pages: 1809 - 1811
      Abstract: There has been a transformational change in understanding heart failure due to transthyretin cardiac amyloidosis (ATTR-CA). Previously considered a rare condition, the widespread adaptation of nuclear imaging to establish the diagnosis has led to the recognition that ATTR-CA is commonly encountered in clinical practice. Additionally, the advent of effective disease-modifying therapies that reduce morbidity and mortality among affected patients has afforded hope to those newly diagnosed. Because these disease-modifying therapies are more effective when administered early in the course of the illness, before significant end-organ dysfunction has occurred, it is vital to facilitate early diagnosis.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.2868
      Issue No: Vol. 331, No. 21 (2024)
       
  • Meaning of Proposed Causal Inference Framework for the JAMA Network

    • Free pre-print version: Loading...

      Pages: 1812 - 1813
      Abstract: The Special Communication “Causal Inferences About the Effects of Interventions From Observational Studies in Medical Journals,” published in this issue of JAMA, provides a rationale and framework for considering causal inference from observational studies published by medical journals. Our intent is to invite discussion of this framework, explore its application in the context of specific study designs, and actively examine how this framework could be implemented and used by authors, peer reviewers, and editors of medical journals, including JAMA and the journals of the JAMA Network. Our overarching goal is to ensure that findings from observational designs may be appropriately interpreted in thoughtful and circumspect manners and applied by readers, other researchers, and clinicians, with the ultimate goal of improving patient care and public and global health.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.8107
      Issue No: Vol. 331, No. 21 (2024)
       
  • Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive
           ALL

    • Free pre-print version: Loading...

      Pages: 1814 - 1823
      Abstract: This randomized trial assesses the effect of ponatinib vs imatinib combined with low-intensity chemotherapy on disease remission in adults with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia (ALL).
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.4783
      Issue No: Vol. 331, No. 21 (2024)
       
  • Cardiovascular Burden of V142I Transthyretin Variant

    • Free pre-print version: Loading...

      Pages: 1824 - 1833
      Abstract: This study used data on Black participants in 4 large observational studies to better define the natural history of disease in V142I variant carriers across mid to late life, assess variant modifiers, and estimate cardiovascular burden to the US population.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.4467
      Issue No: Vol. 331, No. 21 (2024)
       
  • Non–HDL-C Levels From Childhood to Adulthood and CVD Events

    • Free pre-print version: Loading...

      Pages: 1834 - 1844
      Abstract: This study of individual participant data from 6 pooled cohorts assesses whether resolution of elevated childhood non–high-density lipoprotein cholesterol (non–HDL-C) by adulthood is associated with reduced risk of clinical cardiovascular disease (CVD) events.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.4819
      Issue No: Vol. 331, No. 21 (2024)
       
  • Causal Inference and Effects of Interventions From Observational Studies
           in Medical Journals

    • Free pre-print version: Loading...

      Pages: 1845 - 1853
      Abstract: This Special Communication examines drawing causal inferences about the effects of interventions from observational studies in medical journals.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.7741
      Issue No: Vol. 331, No. 21 (2024)
       
  • Service Animals in Health Care Settings

    • Free pre-print version: Loading...

      Pages: 1854 - 1855
      Abstract: This JAMA Insights article reviews Americans with Disabilities Act (ADA) rules for patients, visitors, and other members of the public bringing service animals into health care settings.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.4132
      Issue No: Vol. 331, No. 21 (2024)
       
  • A 3-Year-Old With Gingival Hemorrhage and Musculoskeletal Pain

    • Free pre-print version: Loading...

      Pages: 1856 - 1857
      Abstract: A 3-year-old had spontaneous gingival hemorrhage and bilateral limb weakness with inability to bear weight. He had no preceding oral trauma or recent infection, took no regular medications, and had no recent use of aspirin or nonsteroidal anti-inflammatory drugs; his diet was limited to primarily chicken nuggets and milk. What is the diagnosis and what would you do next'
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.3580
      Issue No: Vol. 331, No. 21 (2024)
       
  • Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults

    • Free pre-print version: Loading...

      Pages: 1858 - 1860
      Abstract: This cross-sectional study assesses the prevalence and temporal evolution of cardiovascular-kidney-metabolic syndrome stages.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.6892
      Issue No: Vol. 331, No. 21 (2024)
       
  • Substances in Counterfeit Prescription Pills Seized by Law Enforcement,
           2017-2022

    • Free pre-print version: Loading...

      Pages: 1860 - 1862
      Abstract: This study examines substances identified during testing of counterfeit prescription pills seized by law enforcement in Rhode Island from 2017 to 2022.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.6161
      Issue No: Vol. 331, No. 21 (2024)
       
  • A Review of Thyroid Cancer

    • Free pre-print version: Loading...

      Pages: 1862 - 1863
      Abstract: To the Editor A recent Review discussed exposure to ionizing radiation as a common risk factor for thyroid cancer. However, it is important to consider additional risk factors for thyroid cancer.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.5998
      Issue No: Vol. 331, No. 21 (2024)
       
  • A Review of Thyroid Cancer

    • Free pre-print version: Loading...

      Pages: 1863 - 1863
      Abstract: To the Editor A recent Review discussed the complexity of thyroid cancer. First, we would like to highlight the importance of distinguishing between benign and malignant thyroid nodules preoperatively.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.5995
      Issue No: Vol. 331, No. 21 (2024)
       
  • A Review of Thyroid Cancer—Reply

    • Free pre-print version: Loading...

      Pages: 1863 - 1864
      Abstract: In Reply We appreciate letters about our Review on thyroid cancer. In response to the comments by Drs Beheshtirouy and Shayanfar, the causal association between GLP-1 RA use and thyroid cancer is complex and requires careful consideration of factors that directly or indirectly influence carcinogenesis pathways such as the direct biological effects of the drug, host susceptibility factors (eg, obesity or proinflammatory states), biases embedded in clinical trials, and length of follow-up. To date, evidence investigating causality of this association is inconclusive, so it is premature and inappropriate to include GLP-1 RA use as a risk factor for thyroid cancer. Increased expression of the GLP-1 receptor has been found in medullary thyroid cancer and in nonmedullary thyroid cancer human cell lines, but GLP-1 RAs did not significantly affect proliferation of these cell lines, signaling pathways, mitochondrial respiration, or glycolysis, suggesting that there is limited carcinogenic evidence of GLP-1 RA in human tissues, particularly in nonmedullary thyroid cancer. In a systematic review and meta-analysis of 64 randomized trials, there were only 26 reporting cases of thyroid cancer associated with use of GLP-1 RAs. Although there was an increased relative risk for thyroid cancer on the fixed-effect meta-analysis (odds ratio, 1.52 [95% CI, 1.01-2.29]), statistical significance was lost in the random-effect analysis (odds ratio, 1.41 [95% CI, 0.91-2.17]), and in the leave-one-out sensitivity analysis of 5 studies. In that systematic review, an analysis that focused on the specific diagnoses of papillary thyroid cancer and medullary thyroid cancer also did not reach statistical significance.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.6001
      Issue No: Vol. 331, No. 21 (2024)
       
  • Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent Patients

    • Free pre-print version: Loading...

      Pages: 1864 - 1865
      Abstract: To the Editor We have some concerns about the recent retrospective public health surveillance study of older female dialysis-dependent patients who were treated with denosumab for osteoporosis.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.6839
      Issue No: Vol. 331, No. 21 (2024)
       
  • Denosumab-Associated Severe Hypocalcemia in Dialysis-Dependent
           Patients—Reply

    • Free pre-print version: Loading...

      Pages: 1865 - 1866
      Abstract: In Reply We thank Drs Schoenmakers and Fraser for their comments on our study. We reported the US experience with denosumab administration among dialysis-dependent patients, finding the weighted cumulative incidence of severe hypocalcemia (ie, <7.5 mg/dL or emergent care) at 12 weeks to be 41.1% with denosumab. We agree that treatment for osteoporosis in our study may have been initiated in some patients with poorly controlled CKD-MBD, highlighting the importance of increased attention to careful patient selection in clinical practice. However, careful patient selection alone may not prevent hypocalcemia, and ongoing careful monitoring is necessary. Hiramatsu et al reported that 12 of 47 dialysis-dependent patients (25.5%) with relatively well-controlled mineral abnormalities receiving supplementation with calcium and vitamin D developed denosumab-associated acute hypocalcemia (ie, ≤8 mg/dL) during a 2-year observational study in Japan.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.6842
      Issue No: Vol. 331, No. 21 (2024)
       
  • Error in the Exclusion of Participants From Analysis in the ACTIV-6
           Platform Randomized Clinical Trial

    • Free pre-print version: Loading...

      Pages: 1866 - 1867
      Abstract: To the Editor On behalf of my coauthors, I write to explain errors that we identified in the Original Investigation “Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial,” published online on February 20, 2023, and in the March 21, 2023, print issue of JAMA. This article reported the findings of the double-blind Accelerating COVID-19 Therapeutic Interventions and Vaccines 6 (ACTIV-6) platform randomized clinical trial of 1206 US adults with COVID-19 who received a targeted dose of 600 μg/kg of ivermectin or placebo for 6 days during February 2022 to July 2022. The primary outcome was time to sustained recovery, defined as at least 3 consecutive days without symptoms. As we reported, “the median time to sustained recovery was 11 days in the ivermectin group and 11 days in the placebo group. In this largely vaccinated (84%) population, the posterior probability that ivermectin reduced symptom duration by more than 1 day was less than 0.1%.”
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.8723
      Issue No: Vol. 331, No. 21 (2024)
       
  • Errors in Results From Erroneous Exclusion of Participants in Analysis

    • Free pre-print version: Loading...

      Pages: 1867 - 1867
      Abstract: The Original Investigation titled “Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial,” published in the March 21, 2023, issue of JAMA, was corrected to fix an error in which 226 participants were erroneously excluded in the initial report. To address these errors, corrections have been made to the Key Points, Abstract, Participants, and Results section of the text of the article and the tables, figures, and supplement. This article was corrected online.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.8712
      Issue No: Vol. 331, No. 21 (2024)
       
  • Thomas, Unsainted

    • Free pre-print version: Loading...

      Pages: 1868 - 1868
      Abstract: Again left fingers enter the chest
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2024.5075
      Issue No: Vol. 331, No. 21 (2024)
       
  • The “Day of Rest” and Human Efficiency

    • Free pre-print version: Loading...

      Pages: 1869 - 1869
      Abstract: The refreshing influence of the weekly recurring “day of rest” on a person subjected to the strenuous routine of a busy life is a feature which he himself can duly appreciate in terms of his “feelings” and “spirits.” If it is desired to demonstrate the need of such relaxation and the benefits derived therefrom in some objective way, a method is not easily forthcoming. The problem is one which, in its broadest aspects, has a far-reaching importance in every community. The efficiency of the working man, the desirable length of the working-day, the interjection of pauses for rest in the schedule of labor for persons of different ages and stations in life—questions of this sort are constantly arising for solution by some plan which excludes purely subjective impressions and permits some more scientific basis for a tenable judgment in the matter. Not only in the field of manual labor, but also in innumerable other walks of life, in the case of the schoolchild, the office-boy, the factory-girl, the banker and the merchant, efficiency is the key-note of the times. Fatigue is the enemy of efficiency; and to detect and compensate for or overcome it, is the duty of those concerned with the promotion of human welfare.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2023.18305
      Issue No: Vol. 331, No. 21 (2024)
       
  • Patient Information: Poison Ivy, Poison Oak, and Poison Sumac

    • Free pre-print version: Loading...

      Pages: 1872 - 1872
      Abstract: This JAMA Patient Page describes allergic skin reactions from contact with poison ivy, poison oak, and poison sumac plants, and how to treat rashes caused by these plants.
      PubDate: Tue, 04 Jun 2024 00:00:00 GMT
      DOI: 10.1001/jama.2023.26355
      Issue No: Vol. 331, No. 21 (2024)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 34.239.151.124
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-